Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Cybin ( (TSE:CYBN) ).
Cybin Inc. announced that its CEO, Doug Drysdale, will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. This participation highlights Cybin’s commitment to advancing mental health treatment and its strategic positioning within the neuropsychiatry industry. The event provides an opportunity for stakeholders to gain insights into the company’s progress and future directions in developing new mental health therapies.
The most recent analyst rating on (TSE:CYBN) stock is a Buy with a C$114.00 price target. To see the full list of analyst forecasts on Cybin stock, see the TSE:CYBN Stock Forecast page.
Spark’s Take on TSE:CYBN Stock
According to Spark, TipRanks’ AI Analyst, TSE:CYBN is a Underperform.
Cybin’s stock score is significantly impacted by its lack of revenue and continuous financial losses, resulting in a low valuation score. While technical indicators are neutral, positive corporate events indicate potential for future growth. However, current financial challenges remain the dominant concern.
To see Spark’s full report on TSE:CYBN stock, click here.
More about Cybin
Cybin Inc. is a clinical-stage neuropsychiatry company focused on revolutionizing mental healthcare by developing innovative next-generation treatment options. The company is addressing the unmet needs of individuals with mental health conditions through its proprietary programs, such as CYB003 and CYB004, which are in advanced stages of clinical development. Established in 2019, Cybin operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.
Technical Sentiment Signal: Hold
Current Market Cap: C$1.97M
For detailed information about CYBN stock, go to TipRanks’ Stock Analysis page.